Trial · NCT02224157
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Annual Severe Asthma Exacerbation Rate - Non-inferiority Analysis | Placebo Bid + Symbicort 'as Needed' (Experimental) | 0.11 | 95% Confidence Interval 0.10 to 0.13 | exacerbations per participant year | |
| Annual Severe Asthma Exacerbation Rate - Non-inferiority Analysis | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 0.12 | 95% Confidence Interval 0.10 to 0.14 | exacerbations per participant year | |
| Number of Participants Experiencing at Least One Severe Asthma Exacerbation | Placebo Bid + Symbicort 'as Needed' (Experimental) | 177 | Participants | ||
| Number of Participants Experiencing at Least One Severe Asthma Exacerbation | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 184 | Participants | ||
| Average Change From Baseline in Pre-bronchodilator FEV1 | Placebo Bid + Symbicort 'as Needed' (Experimental) | 104.0 | 95% Confidence Interval 88.5 to 119.6 | mL | |
| Average Change From Baseline in Pre-bronchodilator FEV1 | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 136.6 | 95% Confidence Interval 121.1 to 152.2 | mL | |
| Number of Participants With Study Specific Asthma Related Discontinuation | Placebo Bid + Symbicort 'as Needed' (Experimental) | 0 | Participants | ||
| Number of Participants With Study Specific Asthma Related Discontinuation | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 4 | Participants | ||
| Average Change From Baseline in 'as Needed' Use | Placebo Bid + Symbicort 'as Needed' (Experimental) | -0.84 | 95% Confidence Interval -0.86 to -0.81 | Number of inhalations per day | |
| Average Change From Baseline in 'as Needed' Use | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | -0.87 | 95% Confidence Interval -0.89 to -0.84 | Number of inhalations per day | |
| Change From Baseline in Percent of 'as Needed' Free Days | Placebo Bid + Symbicort 'as Needed' (Experimental) | 41.01 | 95% Confidence Interval 39.90 to 42.12 | Percentage of 'as needed' free days | |
| Change From Baseline in Percent of 'as Needed' Free Days | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 47.86 | 95% Confidence Interval 46.75 to 48.98 | Percentage of 'as needed' free days | |
| Percentage of Controller Use Days | Placebo Bid + Symbicort 'as Needed' (Experimental) | 30.45 | 95% Confidence Interval 29.20 to 31.70 | Percentage of days | |
| Percentage of Controller Use Days | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 67.92 | 95% Confidence Interval 66.67 to 69.17 | Percentage of days | |
| Average Change From Baseline in Asthma Control Questionnaire (5-item Version) - ACQ-5 Score | Placebo Bid + Symbicort 'as Needed' (Experimental) | -0.35 | 95% Confidence Interval -0.38 to -0.32 | Score | |
| Average Change From Baseline in Asthma Control Questionnaire (5-item Version) - ACQ-5 Score | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | -0.46 | 95% Confidence Interval -0.49 to -0.43 | Score | |
| Average Change From Baseline in Asthma Quality of Life Questionnaire Standardised Version - AQLQ(S) Score | Placebo Bid + Symbicort 'as Needed' (Experimental) | 0.335 | 95% Confidence Interval 0.305 to 0.366 | AQLQ(S) overall score | |
| Average Change From Baseline in Asthma Quality of Life Questionnaire Standardised Version - AQLQ(S) Score | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 0.431 | 95% Confidence Interval 0.400 to 0.461 | AQLQ(S) overall score | |
| Annual Severe Asthma Exacerbation Rate - Superiority Analysis | Placebo Bid + Symbicort 'as Needed' (Experimental) | 0.11 | 95% Confidence Interval 0.10 to 0.13 | exacerbations per participant year | |
| Annual Severe Asthma Exacerbation Rate - Superiority Analysis | Pulmicort Bid + Terbutaline 'as Needed' (Active Comparator) | 0.12 | 95% Confidence Interval 0.10 to 0.14 | exacerbations per participant year |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02224157/results